vs
Side-by-side financial comparison of Orion Properties Inc. (ONL) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
Orion Properties Inc. is the larger business by last-quarter revenue ($35.2M vs $18.3M, roughly 1.9× ROCKWELL MEDICAL, INC.). ROCKWELL MEDICAL, INC. runs the higher net margin — -3.0% vs -101.7%, a 98.7% gap on every dollar of revenue. On growth, Orion Properties Inc. posted the faster year-over-year revenue change (-8.2% vs -25.6%). Over the past eight quarters, ROCKWELL MEDICAL, INC.'s revenue compounded faster (-10.1% CAGR vs -13.6%).
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
ONL vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $35.2M | $18.3M |
| Net Profit | $-35.8M | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | -101.5% | -2.2% |
| Net Margin | -101.7% | -3.0% |
| Revenue YoY | -8.2% | -25.6% |
| Net Profit YoY | -9.3% | 26.7% |
| EPS (diluted) | $-0.63 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $35.2M | $18.3M | ||
| Q3 25 | $37.1M | $15.9M | ||
| Q2 25 | $37.3M | $16.1M | ||
| Q1 25 | $38.0M | $18.9M | ||
| Q4 24 | $38.4M | $24.7M | ||
| Q3 24 | $39.2M | $28.3M | ||
| Q2 24 | $40.1M | $25.8M | ||
| Q1 24 | $47.2M | $22.7M |
| Q4 25 | $-35.8M | $-554.0K | ||
| Q3 25 | $-69.0M | $-1.8M | ||
| Q2 25 | $-25.1M | $-1.5M | ||
| Q1 25 | $-9.4M | $-1.5M | ||
| Q4 24 | $-32.8M | $-756.0K | ||
| Q3 24 | $-10.2M | $1.7M | ||
| Q2 24 | $-33.8M | $343.0K | ||
| Q1 24 | $-26.2M | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | -101.5% | -2.2% | ||
| Q3 25 | -185.8% | -9.9% | ||
| Q2 25 | -67.1% | -8.4% | ||
| Q1 25 | -24.4% | -7.2% | ||
| Q4 24 | -85.4% | -2.1% | ||
| Q3 24 | -25.9% | 6.8% | ||
| Q2 24 | -84.1% | 2.0% | ||
| Q1 24 | -55.4% | -5.8% |
| Q4 25 | -101.7% | -3.0% | ||
| Q3 25 | -186.0% | -11.0% | ||
| Q2 25 | -67.3% | -9.3% | ||
| Q1 25 | -24.6% | -8.0% | ||
| Q4 24 | -85.4% | -3.1% | ||
| Q3 24 | -26.1% | 5.9% | ||
| Q2 24 | -84.2% | 1.3% | ||
| Q1 24 | -55.6% | -7.6% |
| Q4 25 | $-0.63 | $-0.01 | ||
| Q3 25 | $-1.23 | $-0.05 | ||
| Q2 25 | $-0.45 | $-0.05 | ||
| Q1 25 | $-0.17 | $-0.04 | ||
| Q4 24 | $-0.59 | $-0.02 | ||
| Q3 24 | $-0.18 | $0.04 | ||
| Q2 24 | $-0.60 | $0.01 | ||
| Q1 24 | $-0.47 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $22.4M | $10.7M |
| Total DebtLower is stronger | $465.0M | — |
| Stockholders' EquityBook value | $623.2M | $37.0M |
| Total Assets | $1.2B | $57.1M |
| Debt / EquityLower = less leverage | 0.75× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $22.4M | $10.7M | ||
| Q3 25 | $32.6M | $13.6M | ||
| Q2 25 | $17.4M | $12.5M | ||
| Q1 25 | $9.4M | $11.4M | ||
| Q4 24 | $15.6M | $15.7M | ||
| Q3 24 | $16.6M | $12.3M | ||
| Q2 24 | $24.2M | $11.9M | ||
| Q1 24 | $23.6M | $6.6M |
| Q4 25 | $465.0M | — | ||
| Q3 25 | $483.0M | — | ||
| Q2 25 | $483.0M | — | ||
| Q1 25 | $505.0M | — | ||
| Q4 24 | $492.0M | — | ||
| Q3 24 | $485.0M | — | ||
| Q2 24 | $462.0M | — | ||
| Q1 24 | $471.0M | — |
| Q4 25 | $623.2M | $37.0M | ||
| Q3 25 | $658.8M | $37.0M | ||
| Q2 25 | $728.0M | $30.4M | ||
| Q1 25 | $753.5M | $31.5M | ||
| Q4 24 | $763.9M | $32.6M | ||
| Q3 24 | $800.9M | $29.1M | ||
| Q2 24 | $816.1M | $23.5M | ||
| Q1 24 | $854.6M | $20.6M |
| Q4 25 | $1.2B | $57.1M | ||
| Q3 25 | $1.2B | $57.5M | ||
| Q2 25 | $1.3B | $52.6M | ||
| Q1 25 | $1.3B | $54.0M | ||
| Q4 24 | $1.3B | $59.2M | ||
| Q3 24 | $1.4B | $57.1M | ||
| Q2 24 | $1.3B | $53.0M | ||
| Q1 24 | $1.4B | $50.7M |
| Q4 25 | 0.75× | — | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 0.66× | — | ||
| Q1 25 | 0.67× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.61× | — | ||
| Q2 24 | 0.57× | — | ||
| Q1 24 | 0.55× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $23.6M | $2.3M |
| Free Cash FlowOCF − Capex | — | $2.2M |
| FCF MarginFCF / Revenue | — | 12.0% |
| Capex IntensityCapex / Revenue | — | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $23.6M | $2.3M | ||
| Q3 25 | $5.7M | $-1.3M | ||
| Q2 25 | $11.6M | $1.8M | ||
| Q1 25 | $-2.2M | $-3.5M | ||
| Q4 24 | $54.3M | $865.0K | ||
| Q3 24 | $13.8M | $4.3M | ||
| Q2 24 | $17.0M | $1.4M | ||
| Q1 24 | $11.0M | $-2.4M |
| Q4 25 | — | $2.2M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | — | $1.7M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | — | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-2.5M |
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | -9.6% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | — | -18.8% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | — | -11.1% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ONL
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
